Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (33 total)
-
Autor: Katherine J. Siddle, Ph.D., Philomena Eromon, B.Sc., Kayla G. Barnes, Ph.D., Judith U. Oguzie, D.V.M., Samar Mehta, M.D., Ph.D., Ikponmwonsa Odia, M.Sc., Rickey Shah, A.L.M., Patrick Brehio, B.S., Sarah M. Winnicki, M.S., Christopher Iruolagbe,…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2018-11-01
Descripción: In early 2018 Nigeria experienced an unprecedented increase in Lassa fever cases with widespread geographic distribution. -
Autor: Cnops, L., J. van Griensven, A. N. Honko, D. G. Bausch, A. Sprecher, C. E. Hill, R. Colebunders, J. C. Johnson, A. Griffiths, G. F. Palacios, C. S. Kraft, G. Kobinger, A. Hewlett, D. A. Norwood, P. Sabeti, P. B. Jahrling, P. Formenty, J. H. Kuhn, and…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2016-07
Descripción: Quantitative measurement of viral load is an important parameter in the management of filovirus disease outbreaks because viral load correlates with severity of disease, survival, and infectivity. Copyright © 2016 Elsevier Ltd. All rights reserved. -
Autor: Emory
Tema: General
Tipo de elemento: Curso en línea
Fecha de actualización: 2018-01-08
Descripción: Ebola Virus Disease: An Evolving Epidemic - Emory University | CourseraExample only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Autor: the Oxford COVID-19 Vaccine Trial Group
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2021-03-30
Descripción: A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), against this variant. -
Autor: Folarin OA, Ehichioya D, Schaffner SF, Winnicki SM, Wohl S, Eromon P, West KL, Gladden-Young A, Oyejide NE, Matranga CB, Deme AB, James A, Tomkins-Tinch C, Onyewurunwa K, Ladner JT, Palacios G, Nosamiefan I, Andersen KG, Omilabu S, Park DJ, Yozwiak…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2016-10-15
Descripción: Containment limited the 2014 Nigerian Ebola virus (EBOV) disease outbreak to 20 reported cases and 8 fatalities. We present here clinical data and contact information for at least 19 case patients, and full-length EBOV genome sequences for 12 of the… -
Autor: Kaul, D. R., A. K. Mehta, C. R. Wolfe, E. Blumberg, and M. Green
Tema: Decedent Management
Tipo de elemento: Publicación
Fecha de actualización: 2015-01
Descripción: The authors recommend a simple, common‐sense approach to screening deceased and living donors for exposure to Ebola virus and thus reducing the risk of Ebola virus transmission from organ donor to recipient. -
Autor: University of Nebraska Medical Center / Nebraska Medicine
Tema: Training and Exercises
Tipo de elemento: Video
Fecha de actualización: 2021-08-05
Descripción: Dr. Lawler held a news conference on August 5, 2021 to explain the Delta variant of COVID-19. -
Autor: Ellebedy, A. H., K. J. Jackson, H. T. Kissick, H. I. Nakaya, C. W. Davis, K. M. Roskin, A. K. McElroy, C. M. Oshansky, R. Elbein, S. Thomas, G. M. Lyon, C. F. Spiropoulou, A. K. Mehta, P. G. Thomas, S. D. Boyd, and R. Ahmed
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2016-10
Descripción: Antigen-specific B cells bifurcate into antibody-secreting cells (ASCs) and memory B cells (MBCs) after infection or vaccination. -
Autor: State of the Clinical Science Working Group of the National Emerging Pathogens Training and Education Center’s (NETEC) Special Pathogens Research Network (SPRN)
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2024-05
Descripción: Crimean-Congo hemorrhagic fever (CCHF), caused by CCHF virus, is a tickborne disease that can cause a range of illness outcomes, from asymptomatic infection to fatal viral hemorrhagic fever; the disease has been described in >30 countries. We…